Cellectis signed CRISPR/Cas9 licensing deal with University of Minnesota
Cellectis Plant Sciences recently announced it has signed an exclusive licensing agreement with the University of Minnesota, granting the firm worldwide rights to patents covering the use of CRISPR/Cas9 technology in plants. The technology, developed for genome engineering in plants by University of Minnesota Professor...
Read More
CRISPRdirect: software for designing CRISPR guide RNA with reduced off-target sites
Hijacking CRISPR to Fight HIV
Controlling CRISPR
As our understanding of CRISPR technology grows, the extraordinary potential of this gene-editing system in the realm of therapeutic development comes closer and closer to realization. However, ownership of the intellectual property (IP) behind this technology is set to spark a protracted patent feud between...
Read More
CRISPR Chain Reaction
A CRISPR Solution to ‘Bubble Boy’ Disease?
Microbiome Editing with CRISPR/Cas9 Has Research, Diagnostic Potential
NEW YORK (GenomeWeb) – Two of the bacterial kingdom’s greatest assets, the CRISPR “immune” system and horizontal gene transfer of plasmids by conjugation, could be exploited by humans to wipe out specific communities of bacteria or even turn them into useful reporters. CRISPR/Cas9 provides a...
Read More
Building a genomic GPS with CRISPR
Scientists Call for a Summit on Gene-Edited Babies
A group of senior American scientists and ethics experts is calling for debate on the gene-engineering of humans, warning that technology able to change the DNA of future generations is now “imminent.” In policy recommendations published today in the journal Science, eighteen researchers, including two...
Read More